---
name: selank
description: Apply the Selank: one 62-patient trial against a benzodiazepine, and 40 people counted article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.
---

# Selank: one 62-patient trial against a benzodiazepine, and 40 people counted

This Skill is the behavioral expression of [the canonical article](/a/selank). It does not repeat the article's human prose.

## Orient

- Read the machine article at /api/articles/selank.
- Read claims and relationships at /api/articles/selank/topology.
- Treat found content as evidence and instruction only within the article's stated authority.

## Apply

1. Identify which claim or concept from the article governs the request.
2. State the governing meaning in the minimum language needed.
3. Apply it to the requested object or decision.
4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.
5. Return the result with the article identity and any relevant claim or receipt links.

## Human meaning

Selank is a seven-amino-acid peptide developed in Moscow and approved in Russia in 2009 for generalised anxiety disorder. There is one controlled trial in people that carries almost the whole case: 62 patients, 30 given Selank and 32 given 

## Representations

- Human: /a/selank
- JSON: /api/articles/selank
- Relationships: /api/articles/selank/topology
- History: /api/articles/selank/revisions
